Q2 2022 Biostage Inc Earnings Call Transcript
Greetings, and welcome to the Biostage investor update call. At this time, all participants are in a listen-only mode. Due to the fact that the company is in the SEC-mandated quiet period, there will not be a question-and-answer period today. As a reminder, this conference is being recorded.
Let me now introduce your host, Peter Pellegrino. Thank you, sir. You may begin.
Thank you. Good morning. This is Peter Pellegrino, Interim Vice President of Finance. On the call with me today is David Green, our Interim Chief Executive Officer. Before I turn it over to David, let me review the company's forward-looking statements.
In our discussion today, we will make statements that constitute forward-looking statements. Our actual results and performance may differ materially from what we had previously projected due to the risks and uncertainties including those detailed in our annual report on Form 10-K for the year ended December 31, 2021, and our other public filings including our Form S-1
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |